Well past its heyday. - Senior Vaccine Specialist Merck Employee Review

3.0
Aug 19, 2021
Recommend
CEO approval
Business Outlook

Pros

Solid research company until Vioxx. Well educated sales force. Respected by most physicians. Consistent release of new products. Long history of successful products.

Cons

Hard to fully trust since the Vioxx debacle. It use to be patient first. It became market share first. While they purport to be a family like culture, they are not a family. In the end, everyone is just a number.

Explore other reviews about Merck

5.0
Jul 12, 2026
Recommend
CEO approval
Business Outlook

Pros

Work Life Balance, Benefits, Remote Work

Cons

Easy to stagnate if not being proactive about building skills and networking

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All